Cart
sales@molnova.com
Lurtotecan
CAS No. 149882-10-0
Lurtotecan( —— )
Catalog No. M35356 CAS No. 149882-10-0
Lurtotecan (GI147211) is a semisynthetic Camptothecin analog. Lurtotecan is a topoisomerase I inhibitor with anticancer effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 565 | In Stock |
|
| 10MG | 847 | In Stock |
|
| 25MG | 1492 | In Stock |
|
| 50MG | 2009 | In Stock |
|
| 100MG | 2716 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLurtotecan
-
NoteResearch use only, not for human use.
-
Brief DescriptionLurtotecan (GI147211) is a semisynthetic Camptothecin analog. Lurtotecan is a topoisomerase I inhibitor with anticancer effects.
-
DescriptionLurtotecan (GI147211; OSI-211), a semisynthetic Camptothecin analog, is a topoisomerase I inhibitor. Lurtotecan has anticancer effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorTopoisomerase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number149882-10-0
-
Formula Weight518.56
-
Molecular FormulaC28H30N4O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 4.33 mg/mL (8.35 mM; Ultrasonic )
-
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc5OCCOc5cc4c(CN4CCN(C)CC4)c3Cn1c2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. D L Emerson, et al. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. Cancer Res. 1995 Feb 1;55(3):603-9.?
molnova catalog
related products
-
Daniquidone
Daniquidone (Batracylin) is a potent dual inhibitor of DNA topoisomerase I and DNA topoisomerase II with cytotoxic and antiproliferative activity that induces DNA fragmentation for the study of neoplasms, immune disorders, and lymphatic disorders.
-
10-Hydroxycampotheci...
10-Hydroxycamptothecin is a DNA topoisomerase I inhibitor utilized as a clinical therapy agent against hepatoma.
-
Voreloxin
A first-in-class anticancer quinolone derivative that intercalates DNA and inhibits Topoisomerase II.
